Sign in
Taking people in United StatesNo phase

Studying Families with Inherited Blood Cancers to Learn Genetic Causes

Collects family history and samples from families with lymphoma, leukemia, or myeloma.

Key facts

Who runs it
Memorial Sloan Kettering Cancer Center
Where
Basking Ridge, Commack, Harrison, Middletown, New York, and Rockville Centre, United StatesSee the 6 sites
Trial code
Registry title
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status
Recruiting
People taking part
500 people, planned
Started
Jul 2000
Expected to end
Dec 2026
Type of study
Observational
Record updated
23 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with lymphoma, leukemia or multiple myeloma who have a family member with one of these diseases, and for members of such families. It studies the genetic causes of these diseases.

Age
Not limited; children can join if their legal guardian agrees and they agree too.
Sex
All sexes can join.
Disease stage
Lymphoma, lymphoproliferative disease, B-cell cancers or multiple myeloma, in the person or in the family. Several kinds of lymphoma and leukemia are accepted.
Earlier treatment
Women who had radiation treatment for Hodgkin's disease, or who got a second cancer after Hodgkin's disease, can also join.

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Individuals with a personal and/or family history of lymphoma or lymphoproliferative disease B-cell malignancies, or multiple myeloma referred for study participation, or MSK patients referred from to the MSKCC outpatient clinics of the Lymphoma, Multiple Myeloma, or Leukemia Services in the Department of Medicine in consultation for treatment who are found on routine history or through a Family History Questionnaire (FHQ) (Appendix A). Individuals who have relatives or members of successive generations of the family affected with Hodgkin's disease, non-Hodgkin's lymphoma, lymphoid leukemia, multiple myeloma other lymphoproliferative disease prostate or pancreatic cancers, or other conditions suggesting hereditary cancer at the discretion of the MSKCC Principal Investigator. Patients with lymphoma, associated with colon and renal cancer will be eligible for DNA storage through this protocol. Family members or probands with Hodgkin's disease who are women who received therapeutic irradiation for Hodgkin's disease" or who developed secondary cancers after Hodgkin's disease are also eligible for participation
  • The criteria for eligibility are broad because the ascertainment by the computerized FHQ does not allow for resolution of different types of lymphoma or different types of leukemia. Patient recall of this information is also imprecise. More accurate family history information will be obtained upon contact of family members and diagnoses will be verified by obtaining pathologic documentation. The spectrum of familial lymphoproliferative syndromes (LPS) may include all types of lymphoma as well as chronic lymphocytic leukemia. This is an additional reason to have a broad eligibility. Subset analysis will be performed on specific types of lymphoid neoplasms. DNA of patients with a family history of lymphoma who have consented to protocol 93-102 ("Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers") will also be eligible for inclusion in this study
  • Family members of probands including patients, sisters, brothers, halfbrothers and sisters, sons, daughters, grandparents, as well as aunts and uncles are also eligible. An effort will be made to ascertain all living affected and unaffected living relatives in the affected lineage. An emphasis will be on affected sibling pairs and both parents, if alive
  • As this study involves research that presents no greater than minimal risk to children (see Sec. 46.404 of Federal Regulations part 46), minors are also eligible for participation. The assent of any minor should be obtained before the patient is enrolled into this study, as well as the consent of the legal guardian

Who cannot take part

  • N/A

This trial is currently available in United States.

  • Memorial Sloan Kettering Basking RidgeBasking Ridge, United StatesContact: Kenneth Offit, MD, MPHTaking people
  • Memorial Sloan Kettering CommackCommack, United StatesContact: Kenneth Offit, MD, MPHTaking people
  • Memorial Sloan Kettering WestchesterHarrison, United StatesContact: Kenneth Offit, MD, MPHTaking people
  • Memorial Sloan Kettering MonmouthMiddletown, United StatesContact: Kenneth Offit, MD, MPHTaking people
  • Memorial Sloan-Kettering Cancer CenterNew York, United StatesContact: Kenneth Offit, MD, MPHTaking people
  • Memorial Sloan Kettering RockvilleRockville Centre, United StatesContact: Kenneth Offit, MD, MPHTaking people

About the trial

What the trial wants to find out

The purpose of this study is to better understand the genetic causes of Hodgkin's disease (a kind of lymphoma) and non-Hodgkin's lymphoma, as well as multiple myeloma, leukemia, and related diseases. The doctors have identified the patient because 1) they have had a lymphoproliferative disorder such as lymphoma, leukemia, or multiple myeloma, and have a family member with one of these disorders or 2) they are a member of a family with a lymphoproliferative disorder, including Hodgkin's disease and/or, non-Hodgkin's lymphoma or a second cancer after Hodgkin's disease.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Plain-language title
Studying Families with Inherited Blood Cancers to Learn Genetic CausesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
23 January 2026